Primary results from the CLEAR Study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device.
VESALIO announces the successful initial use of its NeVa VS device in the United States for the treatment of post-aneurysmal subarachnoid hemorrhage (aSAH) cerebral vasospasm.
Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology.
MDR certification confirms the company’s commitment of ensuring that their innovative new products meet or exceed these rigorous new standards.
NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture.
The first integrated clot micro-filtration technology for stroke thrombectomy patients.
Important follow up tool to share with newly initiated sites for collecting case feedback during evaluation phase. Can be used on an ongoing basis for collecting feedback in willing sites.
Download Print Ready Version: Digital enVast Procedure Guide A4 Trifold Pocket Format Download Digital Version: enVast Procedure Guide A4 Trifold Pocket Format With Crops PDF to download for printing to provide as a pocket guide to physicians that will use enVast. labs. Leave behind piece. Please follow ENVAST BRANDING GUIDELINES if local adaptation is needed.
Download Print Ready Version: enVast Procedure Guide Poster With Crops | Download Digital Version: Digital enVast Procedure Guide Poster PDF to download for printing to provide as a poster at neuro cath labs. Leave behind piece. Please follow ENVAST BRANDING GUIDELINES if local adaptation is needed.
To be used for presentations to the cath lab staff before enVast use is initiated at a site. Contact Market Development for help if needed. Download Link: Click Here